• Older NSCLC Patients See Many Doctors, Multiple Medications, in Months After Treatment
  • Protagonist Therapeutics Begins Phase 2b Trial of PTG-100 as Ulcerative Colitis Treatment
  • White Matter Hyperintensity May Serve as Biomarker for SCD, Study Says
  • Community-acquired Pneumonia Not ‘Seasonal Disease,’ But Can Often Strike in Winter
  • Possible Early Symptoms of Multiple Sclerosis
  • MYOLYN Seeks FDA Patent for Its MyoCycle Muscle-therapy Bikes
  • Receptor, TNFR2, Identified as Target for Immunotherapy
  • Coherus Reports Positive 24-Week Trial Results for Humira Biosimilar in Psoriasis Patients
  • No Tumors at 30 Months May Be Good Marker in Follicular Lymphoma Therapy Assessments, Study Says
  • EU Grants Orphan Drug Status to Benitec’s Therapy for Oculopharyngeal MD
  • One-Year Anniversary of Lupus Diagnosis: An Affirmation to Speak Life
  • Receiving the Correct Diagnosis is Just the Beginning